BMY
76
2
PCG
74
2
AVY
47
-7
HBAN
82
3
LLY
71
3
CAT
58
-8
URI
46
3
PM
49
2
NTAP
59
4
KO
44
-2
LNC
75
2
CSCO
64
6
DG
74
2
WAT
49
2
SIG
46
2
CAH
63
3
TMO
60
4
CF
48
4
O
33
2
AEP
61
-3
BMY
76
2
PCG
74
2
AVY
47
-7
HBAN
82
3
LLY
71
3
CAT
58
-8
URI
46
3
PM
49
2
NTAP
59
4
KO
44
-2
LNC
75
2
CSCO
64
6
DG
74
2
WAT
49
2
SIG
46
2
CAH
63
3
TMO
60
4
CF
48
4
O
33
2
AEP
61
-3
Financhill
Back

First Trust Indxx Innovative Transactn & Proc ETF Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Buy
80

LEGR
First Trust Indxx Innovative Transactn & Proc ETF

Last Price:
$58.39
Seasonality Move:
0.51%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Buy
80
First Trust Indxx Innovative Transactn & Proc ETF (LEGR) is a Buy

Is First Trust Indxx Innovative Transactn & Proc ETF a Buy, Sell or Hold?

  • The current First Trust Indxx Innovative Transactn & Proc ETF [LEGR] share price is $59.09. The Score for LEGR is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • LEGR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LEGR Stock Price Chart

What is First Trust Indxx Innovative Transactn & Proc ETF's stock price today?

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

LEGR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 61.22 Buy
Chaikin Money Flow: 151 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.76 - 58.68) Buy
Bollinger Bands (100): (54.76 - 58.12) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

LEGR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.53 Buy
20-day SMA: 57.99 Buy
50-day SMA: 57.76 Buy
200-day SMA: 53.61 Buy
8-day EMA: 58.46 Buy
20-day EMA: 58.15 Buy
50-day EMA: 56.65 Buy
200-day EMA: 36.13 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

First Trust Indxx Innovative Transactn & Proc ETF Earnings Growth & LEGR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

First Trust Indxx Innovative Transactn & Proc ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):